Welcome!
Peter Choo
IPO
Peter Choo-backed biomed firm CytoMed lists on Nasdaq
CytoMed Therapeutics was spun off from A*Star
April 17, 2023
TES 800th Issue
Here's where former IPO king Peter Choo thinks Singapore is headed
SINGAPORE (Oct 6): The future is getting harder to forecast in the face of digital disruption, but things are looking up.
October 06, 2017